Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey

Deploying therapeutics for coronavirus disease 2019 (COVID-19) has proved challenging due to evolving evidence, supply shortages, and conflicting guideline recommendations. We conducted a survey on remdesivir use and the role of stewardship. Use differs significantly from guidelines. Hospitals with...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial stewardship & healthcare epidemiology : ASHE 2023, Vol.3 (1), p.e63, Article e63
Main Authors: Mena Lora, Alfredo J, Burgos, Rodrigo, Borgetti, Scott, Chaisson, Lelia H, Bleasdale, Susan C
Format: Article
Language:English
Subjects:
Antiviral drugs
Concise Communication
COVID-19
Cross-sectional studies
Drug stores
Hospitals
Infectious diseases
Pandemics
Polls & surveys
Severe acute respiratory syndrome coronavirus 2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Deploying therapeutics for coronavirus disease 2019 (COVID-19) has proved challenging due to evolving evidence, supply shortages, and conflicting guideline recommendations. We conducted a survey on remdesivir use and the role of stewardship. Use differs significantly from guidelines. Hospitals with remdesivir restrictions were more guideline concordant. Formulary restrictions can be important for pandemic response.
ISSN:2732-494X
2732-494X
DOI:10.1017/ash.2023.146